Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas
- PMID: 10744043
- PMCID: PMC5926230
- DOI: 10.1111/j.1349-7006.2000.tb00858.x
Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas
Abstract
Tumor necrosis factor-alpha (TNF), which was initially supposed to be a promising cancer therapeutic reagent, does not kill most types of cancer cells partly due to the activation of an anti-apoptotic gene, NF-kappaB. NF-kappaB forms an inactive complex with the inhibitor kappa B alpha (IkappaBalpha), which is rapidly phosphorylated and degraded in response to various extracellular signals. To disrupt this protective mechanism, we introduced an inhibitor kappa B alpha (IkappaBdN) gene, a deletion mutant gene lacking the nucleotides for the N-terminal 36 amino acids of IkappaBalpha, into human glioma cells (U251, T-98G, and U-373MG) via an adenoviral (Adv) vector in addition to treatment of the glioma cells with recombinant TNF. Immunohistochemical analysis revealed that NF-kappaB was translocated to nuclei by TNF treatment in U251 and T-98G cells, but not in U-373MG cells. Neither transduction of IkappaBdN nor treatment with TNF protein alone induced apoptosis in U251 and T-98G cells, whereas both cell lines underwent drastic TNF-induced apoptosis after transduction of IkappaBdN. On the other hand, U-373MG cells were refractory to TNF-induced apoptosis even when they were transduced with the IkappaBdN gene. U-373MG cells underwent drastically increased apoptosis when co-transduced with the IkappaBdN and Bax gene in the presence of TNF. Adv-mediated transfer of IkappaBdN or IkappaBdN plus Bax may be a promising therapeutic approach to treat gliomas through TNF-mediated apoptosis.
Similar articles
-
Adenovirus-mediated transfer of caspase-8 in combination with superrepressor of NF-kappaB drastically induced apoptosis in gliomas.Biochem Biophys Res Commun. 2000 May 10;271(2):544-52. doi: 10.1006/bbrc.2000.2615. Biochem Biophys Res Commun. 2000. PMID: 10799332
-
Caspase-9 transduction overrides the resistance mechanism against p53-mediated apoptosis in U-87MG glioma cells.Neurosurgery. 2001 Jul;49(1):177-86; discussion 186-7. doi: 10.1097/00006123-200107000-00027. Neurosurgery. 2001. PMID: 11440440
-
Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas.Cancer Gene Ther. 2000 May;7(5):732-8. doi: 10.1038/sj.cgt.7700160. Cancer Gene Ther. 2000. PMID: 10830720
-
Adenovirus-mediated transfer of bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas.Cancer Gene Ther. 2000 May;7(5):739-48. doi: 10.1038/sj.cgt.7700158. Cancer Gene Ther. 2000. PMID: 10830721
-
Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells.Curr Gene Ther. 2003 Apr;3(2):147-53. doi: 10.2174/1566523034578410. Curr Gene Ther. 2003. PMID: 12653407 Review.
Cited by
-
Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.J Neurooncol. 2003 Feb;61(3):187-96. doi: 10.1023/a:1022554824129. J Neurooncol. 2003. PMID: 12675310
-
Adenovirus-mediated gene transduction of truncated I kappa B alpha enhances radiosensitivity in human colon cancer cells.Cancer Sci. 2003 Aug;94(8):745-50. doi: 10.1111/j.1349-7006.2003.tb01513.x. Cancer Sci. 2003. PMID: 12901803 Free PMC article.
-
Transcriptome-Wide Analysis of CXCR5 Deficient Retinal Pigment Epithelial (RPE) Cells Reveals Molecular Signatures of RPE Homeostasis.Biomedicines. 2020 Jun 1;8(6):147. doi: 10.3390/biomedicines8060147. Biomedicines. 2020. PMID: 32492870 Free PMC article.
-
Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkappaBalpha super-repressor.Cancer Sci. 2003 May;94(5):467-72. doi: 10.1111/j.1349-7006.2003.tb01466.x. Cancer Sci. 2003. PMID: 12824895 Free PMC article.
References
-
- ) Fukumura , D. , Salehi , H. A. , Witwer , B. , Tuma , R. F. , Melder , R. J. and Jain , R. K.Tumor necrosis factor alphainduced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain . Cancer Res. , 55 , 4824 – 4829 ( 1995. ). - PubMed
-
- ) Wright , J. L. and Merchant , R. E.Effects of an intratumoral injection of human recombinant tumor necrosis factor‐alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model . Acta Neuropathol. (Berl.) , 93 , 78 – 86 ( 1997. ). - PubMed
-
- ) Tada , M. , Sawamura , Y. , Sakuma , S. , Suzuki , K. , Ohta , H. , Aida , T. and Abe , H.Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor alpha for the treatment of malignant gliomas . Cancer Immunol. Immunother. , 36 , 251 – 259 ( 1993. ). - PMC - PubMed
-
- ) Del Maestro , R. F. , Lopez‐Torres , M. , Mcdonald , W. B. , Stroude , E. C. and Vaithilingam , I. S.The effect of tumor necrosis factor‐alpha on human malignant glial cells . J. Neurosurg. , 76 , 652 – 659 ( 1992. ). - PubMed
-
- ) Sakuma , S. , Sawamura , Y. , Tada , M. , Aida , T. , Abe , H. , Suzuki , K. and Taniguchi , N.Responses of human glioblastoma cells to human natural tumor necrosis factoralpha: susceptibility, mechanism of resistance and cytokine production studies . J. Neurooncol. , 15 , 197 – 208 ( 1993. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials